Trapezius motor evoked potential in evaluations of corticospinal tract lesions.

BACKGROUND: We wanted to know whether trapezius motor evoked potentials (MEPs) are helpful in the evaluation of corticospinal (CS) lesions above the fifth cervical segment (C5) and compared trapezius MEP measurements in patients with and without radiological evidence of CS lesions. METHODS: Trapezius MEPs were routinely recorded in all MEP studies performed in our hospital. Patients who had MEP studies as well as brain and cervical spine imaging were retrospectively assigned to two groups. Group 1 had radiological evidence of CS lesion above the level of C5 whilst group 2 did not. RESULTS: Forty-nine patients were included in the study. Twenty-eight patients were assigned to group 1 and 21 patients to group 2. The frequencies of abnormal values in the two groups were compared. Twelve (43%) patients in group 1 and three (14%) in group 2 had prolonged MEP latencies. Thirteen patients in group 1 had indentation or impingement of the cervical cord by intervertebral discs as the only relevant radiological abnormality. Seven (54%) of these patients were found to have prolonged trapezius MEP latencies, providing functional correlates to the radiological abnormalities. CONCLUSIONS: Our study gives evidence to the usefulness of trapezius MEP study in the evaluation of CS lesions.

Infective endocarditis secondary to intravenous Subutex abuse.

INTRODUCTION: Subutex (buprenophine) was approved by the Health Science Authority of Singapore for heroin detoxification in 2002. The number of heroin addicts has decreased in Singapore since the introduction of Subutex. However, Subutex abuse and its associated complications became arising medical problems. We report the management of a series of infective endocarditis cases secondary to Subutex abuse. METHODS: We identified 12 cases of infective endocarditis in former heroin addicts treated with Subutex from August 2005 to April 2006. All patients were interviewed by the research coordinator and prospectively followed-up for two years. RESULTS: The treatment period of Subutex endocarditis was often prolonged with a mean hospitalisation stay of 48 days, with 3.8 days in the intensive care unit. Multiple medical complications were noted. Staphylococcus aureus septicaemia accounted for 92 percent of cases. Mortality rate was 42 percent. Failure rate of medical therapy alone was common. 25 percent underwent open heart valve surgery. All patients were subsidised. Mean hospitalisation expenses was S$31,218. CONCLUSION: Subutex endocarditis causes significant morbidity and mortality. It imposes a heavy medical and financial burden to the patient and society. Multidisciplinary treatment involving cardiologists, infectious disease physicians, psychiatrists, surgeons, medical counsellors and social workers is required to manage these patients.

An acute ischemic stroke classification instrument that includes CT or MR angiography: the Boston Acute Stroke Imaging Scale.

BACKGROUND AND PURPOSE: A simple classification instrument based on imaging that predicts outcomes in patients with acute ischemic stroke is lacking. We tested the hypotheses that the Boston Acute Stroke Imaging Scale (BASIS) classification instrument effectively predicts patient outcomes and is superior to the Alberta Stroke Program Early CT Score (ASPECTS) in predicting outcomes in acute ischemic stroke. MATERIALS AND METHODS: Of 230 prospectively screened, consecutive patients with acute ischemic stroke, 87 had noncontrast CT (NCCT)/CT angiography (CTA), and 118 had MR imaging/MR angiography (MRA) at admission and were classified as having major stroke by BASIS criteria if they had a proximal cerebral artery occlusion or, if no occlusion, imaging evidence of significant parenchymal ischemia; all of the others were classified as minor strokes. Outcomes included death, length of hospitalization, and discharge disposition. BASIS was compared with ASPECTS (dichotomized > or

Neuropsychiatric lupus and reversible posterior leucoencephalopathy syndrome: a challenging clinical dilemma.

Reversible posterior leucoencephalopathy syndrome (RPLS) has been increasingly recognized and reported in the literature. While the condition has been well described in patients with acute hypertension, pre-eclampsia, eclampsia, post-transplantation and chemotherapy, RPLS has been increasingly identified in patients with autoimmune diseases such as systemic lupus erythematosus (SLE). Though experience in the diagnosis and management of RPLS in patients with SLE is likely accumulating, few have systematically worked out the strategy to distinguish RPLS from neuropsychiatric SLE (NPSLE) and lupus-related complications of the central nervous system (CNS). Prompt recognition of, and differentiation between, these conditions is essential since their clinical presentations substantially overlap and yet their management strategy and subsequent outcomes can be entirely different. Indeed, inappropriate treatment such as augmentation of immunosuppression may be detrimental to patients with RPLS. A high index of suspicion of RPLS, prompt magnetic resonance imaging of the brain, including diffusion imaging, exclusion of CNS infection and metabolic derangement, a comprehensive medication review accompanied by timely and aggressive control of blood pressure and seizure are keys to successful management of RPLS. Such treatment strategy ensures a very high chance of total neurological recovery in lupus patients with RPLS.

High signal in the cerebrospinal fluid following prior gadolinium administration in a patient with renal impairment.

Increased signal intensity in the cerebrospinal fluid (CSF) on magnetic resonance imaging due to the presence of gadolinium is rarely observed, but has been seen in patients with brain or spinal pathology or underlying renal impairment. We report this phenomenon in a 66-year-old woman with diabetic nephropathy and discuss the possible pathogenesis of the scan findings. Recognition of this unusual finding, and features distinguishing it from other causes of high CSF signal intensity, such as subarachnoid haemorrhage and protein in the CSF, are emphasised to help prevent diagnostic errors.

Reversible splenial lesion in clinically mild encephalitis.

Clinically mild encephalitis with a reversible lesion in the central splenium of the corpus callosum (SCC) is a recently-described clinicoradiological entity. We report a 20-year-old man presenting with fever and a single episode of generalised seizures. Initial magnetic resonance (MR) images showed an ovoid lesion with T1 and T2 signal prolongation, restricted diffusion and decreased apparent diffusion coefficient values in the centre of the SCC, which resolved completely on a repeat MR imaging done three months later. Clinically, the patient had a mild clinical course and made a full recovery. This clinicoradiological entity with an excellent prognosis is elaborated with possible differential diagnoses given. Emphasis is placed on avoiding unnecessary invasive investigation or therapeutic intervention.